Why the study?
Does SR ATPase modulation alter Ca2+ transients and contractility in neonatal rat myocytes?
Does SR ATPase modulation alter Ca2+ transients and contractility in neonatal rat myocytes?
Modulation of the sarcoplasmic reticulum Ca2+ pump directly alters Ca2+ transients and contractile properties in neonatal rat myocytes.
The role of the sarcoplasmic reticulum Ca2+ pump in the excitation-contraction coupling of cardiac muscle fibers was evaluated in experiments on SR ATPase inhibition with thapsigargin or, alternatively, on Ca2+ pump enhancement by SR ATPase transgenic expression. We found that thapsigargin, a highly specific and potent inhibitor of the SR ATPase, produces a strong reduction of cytosolic Ca2+ transient and contractile activation in neonatal rat myocytes, in the absence of any other functional effect. On the other hand, Ca2+ pump enhancement by ATPase transgenic expression affects dramatically Ca2+ transient and twitches, resulting in shorter duration and more rapid decay rates. Of particular interest is gene transfer mediated by recombinant adenovirus vectors under control of a cell-specific promoter, resulting in transgenic expression of all myocytes in culture, and no expression in fibroblasts.
No takes yet. Share an insight, caveat, or question.
Inesi et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: